EDGAR Filing Documents for 0001047469-03-011252

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-03-011252

Filing Date

2003-03-31

Accepted

2003-03-31 15:42:42

Documents

Period of Report

2002-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2105571z10-k.htm	10-K	902992
3	EXHIBIT 2.2	a2105571zex-2_2.txt	EX-2.2	198132
4	EXHIBIT 10.31	a2105571zex-10_31.txt	EX-10.31	24359
5	EXHIBIT 10.32	a2105571zex-10_32.txt	EX-10.32	11601
6	EXHIBIT 21	a2105571zex-21.htm	EX-21	2652
7	EXHIBIT 23.1	a2105571zex-23_1.htm	EX-23.1	1880
8	EXHIBIT 23.2	a2105571zex-23_2.htm	EX-23.2	2522
9	EXHIBIT 23.3	a2105571zex-23_3.htm	EX-23.3	2234
10	EXHIBIT 99.1	a2105571zex-99_1.htm	EX-99.1	5411
11	EXHIBIT 99.2	a2105571zex-99_2.htm	EX-99.2	5683
12	EXHIBIT 99.3	a2105571zex-99_3.htm	EX-99.3	3499
	Complete submission text file	0001047469-03-011252.txt		1163551

Mailing Address

Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000

VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)